EUVIMEDEUVIMED entdecken
Open Access

Coxsackievirus group B3 regulates ASS1-mediated metabolic reprogramming and promotes macrophage inflammatory polarization in viral myocarditis

Qiong Liu iD, Yinpan Shang iD, Ziwei Tao, Xuan Li, Lu Shen, Hanchi Zhang, Zhili Liu, Zhirong Rao, Xiaomin Yu iD, Yanli Cao, Lingbing Zeng, Xiaotian Huang iD

Journal of Virology · 17.09.2024 · 98 (9)

DOI: 10.1128/jvi.00805-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, erschienen am 17.09.2024. Verfasst von Qiong Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Nanchang University and School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, Ch…. Hauptthemen laut MEDLINE: Myocarditis, Enterovirus B, Human, Macrophages, Coxsackievirus Infections. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Training Plan for Academic and Technical Leaders of Major Disciplines in Jiangxi Province-Youth Talent Project, Project for high and talent of Science and Technology Innovation in Jiangxi Double-Thousand Program of Jiangxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coxsackievirus group B3 (CVB3) belongs to the genus Enteroviruses of the family Picornaviridae and is the main pathogen underlying viral myocarditis (VMC). No specific therapeutic is available for this condition. Argininosuccinate synthase 1 (ASS1) is a key enzyme in the urea cycle that converts citrulline and aspartic acid to argininosuccinate. Here, we found that CVB3 and its capsid protein VP2 inhibit the autophagic degradation of ASS1 and that CVB3 consumes citrulline to upregulate ASS1, triggers urea cycle metabolic reprogramming, and then activates macrophages to develop pro-inflammatory polarization, thereby promoting the occurrence and development of VMC. Conversely, citrulline supplementation to prevent depletion can downregulate ASS1, rescue macrophage polarization, and alleviate the pathogenicity of VMC. These findings provide a new perspective on the occurrence and development of VMC, revealing ASS1 as a potential new target for treating this disease. IMPORTANCE Viral myocarditis (VMC) is a common and potentially life-threatening myocardial inflammatory disease, most commonly caused by CVB3 infection. So far, the pathogenesis of VMC caused by CVB3 is mainly focused on two aspects: one is the direct myocardial injury caused by a large number of viral replication in the early stage of infection, and the other is the local immune cell infiltration and inflammatory damage of the myocardium in the adaptive immune response stage. There are few studies on the early innate immunity of CVB3 infection in myocardial tissue, but the appearance of macrophages in the early stage of CVB3 infection suggests that they can play a regulatory role as early innate immune response cells in myocardial tissue. Here, we discovered a possible new mechanism of VMC caused by CVB3, revealed new drug targets for anti-CVB3, and discovered the therapeutic potential of citrulline for VMC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MyocarditisEnterovirus B, HumanMacrophagesCoxsackievirus InfectionsArgininosuccinate SynthaseAnimalsMiceHumansMaleInflammationMyocardiumCapsid ProteinsMetabolic Reprogramming

Stichwörter der Autor:innen

argininosuccinate synthase 1coxsackievirus group B3macrophagesviral myocarditis

Substanzen

Argininosuccinate SynthaseCapsid Proteins

Autor:innen und Institutionen

  • The First Affiliated Hospital of Nanchang University and School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • The Second Clinical Medical College, Nanchang University, Nanchang, China.
  • HuanKui Academy, Nanchang University, Nanchang, China.
  • The First Affiliated Hospital of Nanchang University, School of Public Health, Jiangxi Medical College, Nanchang University, Nanchang, China.

ORCID-Profile: Qiong Liu, Yinpan Shang, Xiaomin Yu, Xiaotian Huang

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • Training Plan for Academic and Technical Leaders of Major Disciplines in Jiangxi Province-Youth Talent Project
  • Project for high and talent of Science and Technology Innovation in Jiangxi Double-Thousand Program of Jiangxi Province
  • National Innovation and Entrepreneurship Training Program for college students

Zitieren

APA

Liu, Q., Shang, Y., Tao, Z., Li, X., Shen, L., Zhang, H., Liu, Z., Rao, Z., Yu, X., Cao, Y., Zeng, L., & Huang, X. (2024). Coxsackievirus group B3 regulates ASS1-mediated metabolic reprogramming and promotes macrophage inflammatory polarization in viral myocarditis. Journal of Virology, 98(9). https://doi.org/10.1128/jvi.00805-24

Vancouver

Liu Q, Shang Y, Tao Z, Li X, Shen L, Zhang H, et al. Coxsackievirus group B3 regulates ASS1-mediated metabolic reprogramming and promotes macrophage inflammatory polarization in viral myocarditis. Journal of Virology. 2024;98(9). doi:10.1128/jvi.00805-24

BibTeX
@article{Liu2024,
  author = {Liu, Qiong and Shang, Yinpan and Tao, Ziwei and Li, Xuan and Shen, Lu and Zhang, Hanchi and Liu, Zhili and Rao, Zhirong and Yu, Xiaomin and Cao, Yanli and Zeng, Lingbing and Huang, Xiaotian},
  title = {Coxsackievirus group B3 regulates ASS1-mediated metabolic reprogramming and promotes macrophage inflammatory polarization in viral myocarditis},
  journal = {Journal of Virology},
  year = {2024},
  volume = {98},
  number = {9},
  doi = {10.1128/jvi.00805-24}
}
Kostenlos starten →